| Overexpression of the proto-oncogene/translation factor 4E in breast-carcinoma cell lines. | breast, |
| Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. | skin, |
| Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview. | neuroblastoma, |
| Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines. | lung, |
| [The effect of 2 ,5 -oligoadenylates on the expression of the cellular proto-oncogene c-myc during the development of Svec s leukemia in rats]. | leukemia, |
| C-myc oncogene expression in human melanoma and its relationship with tumour antigenicity. | skin, |
| Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients. | lung, |
| Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesions. | skin, |
| Expression of bcl-2 oncoprotein in pituitary tumours: comparison with c-myc. | pituitary, |
| Induction of pgp3 expression and reversion of the multidrug resistance phenotype in 9-OH-ellipticine-resistant Chinese hamster lung fibroblasts transfected with the MYC oncogene. | lung, |
| Double minute chromosomes contain amplified c-myc oncogene sequences in acute myeloid leukemia. | leukemia, |
| Abnormal c-myc oncogene DNA methylation in human bladder cancer: possible role in tumor progression. | bladder, |
| Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene. | breast, |
| Alterations of level of total genomic DNA methylation and pattern of c-myc, c-Ha-ras oncogene methylation in human gastric carcinogenesis. | gastric, |
| [Analysis of DNA methylation pattern of c-myc oncogene in hepatocellular carcinoma]. | liver, |
| [Efficacy of interferon alpha in primary prevention of preneoplastic lesions in a transgenic murine model of hepatocellular carcinoma related to the interaction between woodchuck hepatitis viruses and c-myc oncogene]. | liver, |
| Alterations of the metastasis suppressor gene nm23 and the proto-oncogene c-myc in human testicular germ cell tumors. | testicular, |
| Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines. | neuroblastoma, |
| Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma. | skin, |
| Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. | liver, |